Home > Insider Trading > Filing (0001567619-19-011697)

Filing Details

Accession Number:: 0001567619-19-011697
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-20 18:36:33
Reporting Period:: 2019-05-16

Accepted Time:: 2019-05-20 18:36:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1433714	Castlight Health Inc.	CSLT	Services-Computer Processing & Data Preparation (7374)	261989091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1717376	Eric M.p. Chan	C/O Castlight Health, Inc. 150 Spear St., Suite 400 San Francisco CA 94105	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class B Common Stock	Acquisiton	2019-05-15	4,688	$0.00	23,143	No	4	M	Direct
Class B Common Stock	Acquisiton	2019-05-16	1,563	$0.00	24,706	No	4	M	Direct
Class B Common Stock	Acquisiton	2019-05-16	1,875	$0.00	26,581	No	4	M	Direct
Class B Common Stock	Disposition	2019-05-17	2,774	$3.51	23,807	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class B Common Stock	Restricted Stock Units	Disposition	2019-05-16	4,688	$0.00	4,688	$0.00
Class B Common Stock	Restricted Stock Units	Disposition	2019-05-16	1,563	$0.00	1,563	$0.00
Class B Common Stock	Restricted Stock Units	Disposition	2019-05-16	1,875	$0.00	1,875	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,875	No	4	M	Direct
17,185	No	4	M	Direct
28,125	No	4	M	Direct

Footnotes

Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 14, 2017, the grant of which was previously reported on a Form 4 by the Reporting Person.
Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported on a Form 4 by the Reporting Person.
Release and settlement of RSUs granted to the Reporting Person on February 13, 2019, the grant of which was previously reported on a Form 4 by the Reporting Person.
Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
Represents the weighted average sales price per share. The shares sold at prices ranging from $3.48 to $3.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
25% of the RSUs will vest on November 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.